Muscle mass and association to quality of life in non-small cell lung cancer patients.

about

Development and validation of a clinically applicable score to classify cachexia stages in advanced cancer patients.Associations of obstructive sleep apnea with truncal skeletal muscle mass and density.Modulating Metabolism to Improve Cancer-Induced Muscle Wasting.

P2860

Q47548848-AF8AA43F-A8F1-4BF3-9D00-B6EC36B75DAC Q55048443-47278C9B-95F1-4530-86C1-6BCFD4C54D04 Q55301138-B505E001-1DFE-40F9-ABD8-11B75B694BEF

P2860

Muscle mass and association to quality of life in non-small cell lung cancer patients.

Item

http://www.wikidata.org/entity/Q38792305

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Muscle mass and association to quality of life in non-small cell lung cancer patients.

@en

type

Item

label

Muscle mass and association to quality of life in non-small cell lung cancer patients.

@en

prefLabel

Muscle mass and association to quality of life in non-small cell lung cancer patients.

@en

P1476

Muscle mass and association to quality of life in non-small cell lung cancer patients.

@en

P2093

Bjørg Sjøblom

http://www.w3.org/2001/XMLSchema#string

Bjørn H Grønberg

http://www.w3.org/2001/XMLSchema#string

Marianne J Hjermstad

http://www.w3.org/2001/XMLSchema#string

Marit Jordhøy

http://www.w3.org/2001/XMLSchema#string

Nina Aass

http://www.w3.org/2001/XMLSchema#string

Roy M Bremnes

http://www.w3.org/2001/XMLSchema#string

Vickie E Baracos

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Nutritional support in multimodal therapy for cancer cachexia

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity.

Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer.

Cachexia: a new definition.

Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service

Definition and classification of cancer cachexia: an international consensus.

Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis.

P304

759-767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCSM.12206

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tore Wentzel-Larsen

A Bye

Øystein Fløtten

P577

2017-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28493418

http://www.w3.org/2001/XMLSchema#string

P932

5659054

http://www.w3.org/2001/XMLSchema#string

Muscle mass and association to quality of life in non-small cell lung cancer patients.

about

P2860

P2860

Muscle mass and association to quality of life in non-small cell lung cancer patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932